Gene Expression Signatures of Blood Cells After Heart Transplantation
Author Information
Author(s): Shahzad Khurram, Cadeiras Martin, Memon Sarfaraz, Zeeberg Barry, Klingler Tod, Sinha Anshu, Tabak Esteban G., Unniachan Sreevalsa, Deng Mario C.
Primary Institution: Columbia University, New York, NY, USA
Hypothesis
PBMC gene expression profiles can identify patients at risk of cardiac allograft vasculopathy (CAV).
Conclusion
The study suggests that gene expression profiles of peripheral blood mononuclear cells may help evaluate patients at risk of CAV.
Supporting Evidence
- Over 300 genes were differentially expressed with a false discovery rate (FDR) of less than 5%.
- 18 gene ontology categories were enriched, including macrophage activation and interleukin-6 pathway.
- 6 out of 8 transcripts were confirmed through RT-PCR analysis.
Takeaway
Scientists looked at blood cells from heart transplant patients to see if they could tell who might get sick later. They found some clues in the genes that could help doctors catch problems early.
Methodology
The study analyzed gene expression profiles from microarrays of blood samples from 10 post-transplant patients, comparing those who developed advanced CAV to those who did not.
Potential Biases
The study's findings may be influenced by the small number of patients and the retrospective nature of the analysis.
Limitations
The study had a small sample size and relied on angiography, which is not a perfect method for detecting CAV.
Participant Demographics
The study included 10 post-transplant patients, with 3 developing advanced CAV and 7 not.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website